Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1994 Aug 1;151(3):353–355.

Reproductive technology and postmenopausal motherhood.

E H Kluge 1
PMCID: PMC1336935  PMID: 8039093

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991 Aug;18(2):349–355. doi: 10.1016/0735-1097(91)90585-w. [DOI] [PubMed] [Google Scholar]
  2. Cook D. J., Guyatt G. H., Laupacis A., Sackett D. L. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992 Oct;102(4 Suppl):305S–311S. [PubMed] [Google Scholar]
  3. Ezekowitz M. D., Bridgers S. L., James K. E., Carliner N. H., Colling C. L., Gornick C. C., Krause-Steinrauf H., Kurtzke J. F., Nazarian S. M., Radford M. J. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992 Nov 12;327(20):1406–1412. doi: 10.1056/NEJM199211123272002. [DOI] [PubMed] [Google Scholar]
  4. Hirsh J., Dalen J. E., Deykin D., Poller L. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1992 Oct;102(4 Suppl):312S–326S. doi: 10.1378/chest.102.4.312s. [DOI] [PubMed] [Google Scholar]
  5. Lancaster T. Anticoagulation in patients with atrial fibrillation. Atrial fibrillation associated with aging. BMJ. 1993 Dec 4;307(6917):1494–1494. doi: 10.1136/bmj.307.6917.1494-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. O'Reilly R. A., Aggeler P. M. Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose. Circulation. 1968 Jul;38(1):169–177. doi: 10.1161/01.cir.38.1.169. [DOI] [PubMed] [Google Scholar]
  7. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  8. Poller L. Laboratory control of anticoagulant therapy. Semin Thromb Hemost. 1986 Jan;12(1):13–19. doi: 10.1055/s-2007-1003531. [DOI] [PubMed] [Google Scholar]
  9. Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987 Sep;147(9):1561–1564. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES